The mechanisms of compound 48/80-induced superoxide generation mediated by A-kinase in rat peritoneal mast cells

Biochemical and Molecular Medicine

Volumn 61, Issue 1, 1997, Pages 107-113

  Fukuishi, Nobuyuki ^a   Sakaguchi, Masakiyo ^a   Matsuura, Shiori ^a   Nakagawa, Chizuko ^a   Akagi, Reiko ^b   Akagi, Masaaki ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE ACTIVATOR; ARACHIDONIC ACID; ARACHIDONYL TRIFLUOROMETHYL KETONE; BUCLADESINE; COMPOUND 48-80; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; HISTAMINE; ISOPRENALINE; KT 5720; MANOALIDE; PHOSPHOLIPASE A2 INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PERITONEUM MAST CELL; RAT; REGULATORY MECHANISM;

ANIMALIA;

EID: 0031171010     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1997.2594     Document Type: Article

References (35)

1. 1. McCord JM. Free radical and inflammation: Protection of synoval fluid by superoxide dismutase. Science 185:529-531, 1974.
2. 2. Granger DN. Role of xanthin oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 255:H1269-H1275, 1988.
3. 3. Ohyanagui Y. Participation of superoxide anions at the prostaglandin phase of carrageenan food-oedema. Biochem Pharmacol 25:1465-1472, 1976.
4. 4. Satriano JA, Shuldiner M, Hora K, Xing Y, Shan Z, Schlondorff D. Oxygen radicals as second messengers for expression of the monocytechemoattractant protein, JE/MCP-1, and the monocyte colony stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 92:1564-1571, 1993.
5. 5. Katusic Z, Vanhoutte P. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 257:H33-H37, 1989.
6. 6. Cosetino F, Sill JC, Ifatusic ZS. Role of superoxide anion in the mediation of endothelium-dependent contraction. Hypertension 23:229-235, 1994.
7. 7. Kilgore KS, Lucchesi BR. Free radicals and the inflammatory response. In Oxidative Stress, Lipoproteins and Cardiovascular Dysfunction (Evans CR, Bruckdorfer KR, Eds.). London: Portland Press Ltd., 1995, pp 161-180.
8. 8. Schinetti ML, Mazzini A, Greco R, Bertelli A. Inhibiting effect of levamisole on superoxide production from rat mast cells. Pharmacol Res Comm 16:101-107, 1984.
9. 9. Mannaioni PF, Masini E, Pistelli A, Salvemini D, Vane JR. Mast cells as a source of superoxide anions and nitric oxide-like factor: Relevance to histamine release. Int J Tiss Reaction 13:271-278, 1991.
10. 10. Akagi M, Mio M, Tasaka K. Histamine release inhibition and prevention of the decrease in membrane fluidity induced by certain anti-allergic drugs: Analysis of the inhibitory mechanism of NCO-650. Agents Actions 13:149-156, 1983.
11. 11. Jackson SH, Malech HL, Kozak CA, Lomax KI, Gallin JI, Holland SM. Cloning and functional expression of the mouse homolog of p47phox. Immunogenetics 39:272-275, 1994.
12. 12. Fernandez BR. Coupling of synthetic peptides to carrier proteins. In Methods in Cellular Immunology (Fernandez BR, Vetvicka V, Eds.). New York: CRC Press, 1995, pp 170-175.
13. 13. Cooper HM, Paterson Y. Production of polyclonal antisera. In Current Protocols in Immunology (Coligan JE, Krusbeek AM, Margulies DH, Shevach EM, Strober W, Eds.). Wiley, 1994, pp 2.4.1-2.4.9.
14. 14. Hornbeck P. Enzyme-linked immunosorbent assays. In Current Protocols in Immunology (Coligan JE, Krusbeek AM, Margulies DH, Shevach EM, Strober W, Eds.). Wiley, 1994, pp 2.1.2-2.1.6.
15. 15. Ikawa K, Tsutsumi H. Immunoperoxidase staining. In Medical Technology. Tokyo: Ishiyaku 1988, pp 155-161.
16. 16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970.
17. 17. Poylon RO, Goehring B, Droste M, Sovarino KA, Allen LA, Zhao XJ. Cytochrome-C oxidase from Saccharomyces cerevisiae. In Methods in Enzymology, Vol. 260. San Diego: Academic Press, 1995, pp 114-115.
18. 18. Otto JJ. Immunoblotting. In Methods in Cell Biology, Vol. 37. San Diego: Academic Press, 1993, pp 105-117.
19. 19. Nakano M. Determination of superoxide radical and singlet oxygen based on chemiluminescence of luciferin analogs. In Methods in Enzymology (Packer L, Glazer AN, Eds.). San Diego: Academic Press, 1990, pp 585-591.
20. 20. Abo A, Boyhan A, West I, Thrasher AJ, Segal AW. Reconstitution of neutrophil NADPH oxidase activity in the cell-free system by four components: p67-phox, p47-phox, p21rac1, and Cytochrome b245. J Biol Chem 267:16767-16770, 1992.
21. 21. Parkinson JF, Gabig TG. Phagocyte NADPH-oxidase. J Biol Chem 263:8859-8863, 1988.
22. 22. Kyie J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105-132, 1982.
23. 23. Badwey JA, Curnette JT, Karnovsky ML. cis-polyunsaturated fatty acids induce high levels of superoxide production by human neutrophils. J Biol Chem 256:12640-12643, 1981.
24. 24. McPhail LC, Qualliotine-Mann D, Waite KA. Cell free activation of neutrophil NADPH oxidase by a phosphatidic acid-regulated protein kinase. Proc Natl Acad Sci USA 92:1731-7935, 1995.
25. 25. Okano Y, Ishiznka Y, Nakashima S, Tohmatsu T, Takagi H, Nozawa Y. Arachidonic acid release in rat peritoneal mast cells stimulated with antigen, ionophore A23187, and compound 48/80. Biochem Biophys Res Commun 127:726-732, 1985.
26. 26. Lister MD, Glaster KB, Ulevitch RJ, Dennis EA. Inhibition studies on the membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like p388 D1 cells. J Biol Chem 264:8520-8526, 1989.
27. 27. Riendeau D, Guay J, Weech PK, Laliberte F, Yergey J, Li C, Desmarais S, Perrier H, Liu S, Griffith DN, Street IP. Arachidonyl trifluorometyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionopore-challenged platelets. J Biol Chem 269:15619-15624, 1994.
28. 28. Bartoli F, Lin H, Ghomashchi F, Gelb MH, Jain MK, Castro RA. Tight binding inhibitor of 85-kDa phospholipase A2 but not 14-kDa phospholipase A2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J Biol Chem 269:15625-15630, 1994.
29. 29. Lehmeyer JE, Johnston RB. Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the relase of toxic oxigen metabolites by phagocyles: Studies in a model of tissue-bound Ig E. Clin Immunol Immunopathol 9:482-490, 1978.
30. 30. Seamon KB, Daly JW. Forskoline: Its biological and chemical properties. Adv Cyclic Nucleotide Protein Phosphorylation Res 20:141-150, 1986.
31. 31. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A, Kaneko M. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 142:436-440, 1987.
32. 32. Quilliam L, Mueller H, Bohl B, Prossnitz V, Sklar L, Der C, Bokoch G. Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophils. J Immunol 147:1628-1635, 1991.
33. 33. Kitayama H, Sugimoto Y, Matuszaki T, Ikawa Y, Noda M. A ras-related gene with transformation suppressor activity. Cell 56:77-84, 1989.
34. 34. Zhang K, Noda M, Vass C, Papageorge G, Lowy R. Identification of small clusters of divergent amino acid that mediate the opposing effect of ras and Krev-1. Science 249:162-165, 1990.
35. 35. Bokoch GM, Quilliam LA, Bohl BP, Jesaitis AJ, Quinn MT. Inhibition of Rap IA binding to cyiochrome b558 of NADPH oxidase by phosphorylation of Rap 1A. Science 254:1794-1796, 1991.